{"id":"W2101265600","doi":"10.1200/jco.2013.54.8404","title":"Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline","year":2014,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Université de Montréal; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Genentech; Astellas Pharma; Bayer HealthCare; Sanofi; Exelixis; AstraZeneca; American Society of Clinical Oncology; GlaxoSmithKline; Cancer Care Ontario; Amgen; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Cabazitaxel; Docetaxel; Enzalutamide; Prostate cancer; Internal medicine; Oncology; Abiraterone acetate; Prednisone; Mitoxantrone; Androgen deprivation therapy; Cancer; Chemotherapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004857351,0.0009833809,0.001609097,0.002283406,0.001118008,0.001311208,0.003847135,0.0037375,0.004746463],"category_scores_gemma":[0.01107845,0.0005934889,0.00238231,0.002951971,0.0008356594,0.001139626,0.001328447,0.003738925,0.00289107],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007023113,"about_ca_system_score_gemma":0.02504968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.116278,"about_ca_topic_score_gemma":0.2249756,"domain_scores_codex":[0.9960285,0.001234513,0.0009607149,0.0002007781,0.00132929,0.0002462205],"domain_scores_gemma":[0.9910265,0.001173265,0.001769797,0.0001621922,0.00515403,0.0007140914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008248176,0.0001199692,0.002345911,0.007882788,0.0002201238,0.0002974673,0.000262024,0.001197763,0.0005889214,0.002462064,0.8135386,0.1710019],"study_design_scores_gemma":[0.000596215,0.0001240311,0.01230597,0.0334235,0.0006887795,0.0008514905,0.0002316794,0.00156305,0.0003839034,0.004039767,0.9457029,0.00008859536],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008313386,0.3626875,0.02758373,0.3615896,0.01010689,0.01188459,0.03115517,0.001308179,0.1853708],"genre_scores_gemma":[0.06081801,0.4806915,0.1771645,0.1351614,0.005789766,0.01409437,0.06603584,0.0004672715,0.05977745],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.116278,"threshold_uncertainty_score":0.2312025,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3033643931063716,"score_gpt":0.6127817755872027,"score_spread":0.3094173824808311,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}